Randomized phase III trial comparing ABVD plus radiotherapy with the Stanford V regimen in patients with stages I or II locally extensive, bulky mediastinal Hodgkin lymphoma: A subset analysis of the North American Intergroup E2496 trial

Ranjana H. Advani*, Fangxin Hong, Richard I. Fisher, Nancy L. Bartlett, K. Sue Robinson, Randy D. Gascoyne, Henry Wagner, Patrick J. Stiff, Bruce D. Cheson, Douglas A. Stewart, Leo I. Gordon, Brad S. Kahl, Jonathan W. Friedberg, Kristie A. Blum, Thomas M. Habermann, Joseph M. Tuscano, Richard T. Hoppe, Sandra J. Horning

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized phase III trial comparing ABVD plus radiotherapy with the Stanford V regimen in patients with stages I or II locally extensive, bulky mediastinal Hodgkin lymphoma: A subset analysis of the North American Intergroup E2496 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences